ETH News

Researchers at ETH Zurich are utilising artificial intelligence to analyse the behaviour of laboratory mice more efficiently and reduce the number of animals in experiments.

Researchers at ETH Zurich have developed a cell-based bone model to help investigate the cause of this genetic condition.

Organoids grown from human stem cells can help provide answers to important medical questions. In a partnership that looks set to profit both sides, ETH professor Barbara Treutlein has teamed up with pharma giant Roche to advance research in this area.

Researchers at ETH Zurich have developed a method that lets them genetically modify each cell differently in animals. This allows them to study in a single experiment what used to require many animal experiments. Using the new method, the researchers have discovered genes that are relevant for a severe rare genetic disorder.

The CRISPR-Cas gene scissors enable researchers to study the genetic and cellular causes of autism in the lab – directly on human tissue.

Up to now, the use of models to research the barrier that separates the circulatory from the nervous system has proven to be either limited or extremely complicated. Researchers at ETH Zurich have developed a more realistic model that can also be used to better explore new treatments for brain tumours.

Researchers at ETH Zurich are growing human brain-like tissue from stem cells and are then mapping the cell types that occur in different brain regions and the genes that regulate their development.

Researchers have developed a new method that uses artificial intelligence to analyse animal behaviour. This opens the door to longer-term in-depth studies in the field of behavioural science – while also helping to improve animal welfare. The method is already being tested at Zurich Zoo.

ETH Zurich and the other Swiss universities are committed to reducing the stress and suffering experienced by laboratory animals. However, an outright ban on animal testing – being put to the vote in a popular initiative this coming February – would put an end to progress in medical research.

It’s a good thing if animal testing is widely discussed in society, says Detlef Günther, but it’s important that these discussions are fair and fact-based.

Researchers at ETH Zurich have developed a cell culture test to detect substances that are directly or indirectly harmful to embryos. Based on an existing test used for developing new drugs and chemicals, the augmented version is designed to help reduce the number of animal experiments.

Without animal experiments there would be no COVID-19 vaccine: animal testing is essential for medical research. A ban on testing – even a gradual phase-out – would be extremely damaging for research policy, writes Detlef Günther.

ETH researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that new medications may have on embryos early on in the drug development process.

Using artificial intelligence in drug design would give pharmaceutical research a boost, says Gisbert Schneider. In the medium term, computers could even carry out experiments autonomously.

If the federal popular initiative for a blanket ban on animal testing succeeds, drug development in Switzerland would become virtually impossible, ETH Vice President Detlef Günther believes.

Researchers at ETH Zurich have developed a new cell culture method, which may very well enable to forgo certain tests on animals in the future. The scientists were awarded an international prize for more humane treatment of laboratory animals.

Researchers are attempting to study the interactions between different cell types of the human body by using cultured cells. Technology recently developed at ETH Zurich now enables a network comprising spherical microtissues in hanging drops that is intended to simulate interactions in a human body and enables the testing of pharmacologically active substances under realistic conditions.